Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001089181 | SCV000751570 | likely benign | Duchenne muscular dystrophy | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000732779 | SCV000860765 | uncertain significance | not provided | 2018-04-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000732779 | SCV001805762 | likely benign | not provided | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004992411 | SCV005566456 | likely benign | Cardiovascular phenotype | 2024-10-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001829767 | SCV002085420 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-06-29 | no assertion criteria provided | clinical testing |